Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesFerumoxytol for treatment of iron deficiency anemia in patients with chronic kidney disease
Expert Opinion in Pharmacotherapy, 10/05/09
Coyne DW – Ferumoxytol offers substantial safety and superior efficacy compared with oral iron therapy. As ferumoxytol can be administered as 510 mg in < 1 min, it is substantially more convenient than other iron products in nondialysis patients. Although further experience with this product is needed in patients at higher risk of drug reactions, ferumoxytol is likely to be highly useful in the hospital and outpatient settings for treatment of IDA.
Related Articles
Iron-Refractory Iron Deficiency Anemia
Seminars in Hematology, 10/05/09
Relevance Score: 71%
Iron deficiency anemia in infancy and reach and grasp development
Infant Behavior and Development, 11/18/09
Relevance Score: 70%
A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases
World Journal of Gastroenterology, 10/14/09
Relevance Score: 69%
Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia
Hemodialysis International, 11/05/09
Relevance Score: 68%
Trichuris dysentery syndrome: a common cause of chronic iron deficiency anemia in adults in an endemic area
Gastrointestinal Endoscopy, 11/03/09
Relevance Score: 68%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Magnesium sulphate in the treatment of acute asthma: evaluation of current practice in adult emergency departments
Emergency Medicine Journal, 12/02/09
Clinical Studies of Liraglutide, a Novel, Once-Daily Human Glucagon-Like Peptide-1 Analog for Improved Management of Type 2 Diabetes Mellitus
Pharmacotherapy, 12/02/09
The Intersection of Safety and Adherence: New Incretin-Based Therapies in Patients with Type 2 Diabetes Mellitus
Pharmacotherapy, 12/02/09
Sponsor
Article Search
Sponsor